Previous close | 0.7762 |
Open | 0.8114 |
Bid | 0.8102 x 900 |
Ask | 0.8849 x 900 |
Day's range | 0.7762 - 0.8665 |
52-week range | 0.6800 - 19.8700 |
Volume | |
Avg. volume | 346,870 |
Market cap | 29.807M |
Beta (5Y monthly) | 1.94 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of 1.14% and 13.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of -16.09% and 27.40%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Clovis (CLVS) delivered earnings and revenue surprises of -2.33% and 7.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?